Targeting central β2 receptors ameliorates streptozotocin-induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice
Keywords: Aβ; amyloid β protein; AD; Alzheimer's disease; β2AR; β2 adrenoceptor; FAD; familial AD; F; formoterol; GSH; reduced glutathione; GSK-3; glycogen synthase kinase-3; GSK α and β; glycogen synthase kinase alpha and beta; H&E; hematoxylin &eosin; Iba1;